Origin Sciences is a medical technology company that develops innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Our current specific focus is on the diagnosis of colorectal cancer (CRC).
Origin is based in Cambridge and London, UK and was established in 2004. We have a lean but highly experienced management and research team, with a particular focus on innovation and product delivery. We are ISO 13485 accredited.
Origin holds significant proprietary intellectual property relating to a unique medical device – Oricol™ – used for the collection of rectal mucosa in human subjects. It is a very novel and useful tool with a vast range of potential applications.
We aim to be at the forefront of scientific breakthroughs in investigating gastrointestinal disease.